L. I. Vardaev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
L. I. Vardaev has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- K. E. Mironov
Central Clinical Hospital “Russian Railways Medicine”; Russian University of Medicine, Ministry of Health of Russia
2 shared publications - O. E. Lutsevich
Russian University of Medicine
2 shared publications - A. O. Terekhova
Central Clinical Hospital “Russian Railways Medicine”; MedSwiss Medical Center
1 shared publication - R.V. Ipatkin
Central Clinical Hospital «RZD-Medicine
1 shared publication - S.G. Suvorova
Russian University of Medicine
1 shared publication А. О. Терехова
ЧУЗ «Центральная клиническая больница “РЖД-Медицина”»; Медицинский центр MedSwiss
1 shared publication
Latest Publications
- Open Access
- 15 October 2026
- Published by "MedINK" Publishing House in Title
- Vol. 1 (1) , 74-84
One-anastomosis gastric bypass and oral semisynthetic penicillins bioavailability: Clinical pharmacology analysis
Introduction . One-anastomosis gastric bypass (OAGB) is a bypass bariatric procedure that combines restrictive and malabsorptive components and is associated with anatomical changes in the upper gastrointestinal tract. After this operation, the food stream bypasses the duodenum and the proximal jejunum, which may affect the absorption of oral medications, including semisynthetic penicillins. Objective . To assess the potential effect of OAGB on the bioavailability of oral semisynthetic penicillins and to define clinical pharmacology approaches to their use in patients after this type of bypass bariatric procedure. Materials and methods . A review and clinical pharmacology analysis of published data were performed. The search included studies on anatomical and physiological changes after bariatric surgery, mechanisms of intestinal absorption of amoxicillin, ampicillin, amoxicillin with clavulanic acid, and penicillinase-resistant isoxazolyl penicillins, primarily oxacillin, as well as studies on the pharmacokinetics of oral antibiotics after bypass bariatric procedures. The literature search was conducted in international and Russian scientific databases, including PubMed, Cochrane Library, Google Scholar, Crossref, eLibrary.ru, and CyberLeninka, as well as on the websites of scientific journals and publishers. Publications with verifiable digital object identifiers and Russian sources on bariatric surgery were additionally analyzed. Results and discussion . No direct clinical pharmacokinetic studies of oral semisynthetic penicillins specifically after one-anastomosis gastric bypass were identified in the available literature. Most evidence comes from studies after Roux-en-Y gastric bypass and suggests that systemic exposure to amoxicillin may be unpredictable, especially when solid dosage forms are used. Potentially relevant factors include exclusion of the proximal small intestine, changes in gastric pouch acidity, accelerated intestinal transit, dosage form, hypoalbuminemia, and signs of malabsorption. Conclusion . Oral penicillins after OAGB should not be considered inherently ineffective. However, their use requires assessment of infection severity, dosage form, preserved oral intake, and early clinical response. In severe infection, systemic inflammatory manifestations, or signs of unreliable oral exposure, parenteral administration is preferable.
- 15 October 2026
- Published by "MedINK" Publishing House in Title
- Vol. 1 (1) , 74-84
Open AccessOne-anastomosis gastric bypass and oral semisynthetic penicillins bioavailability: Clinical pharmacology analysis
Introduction . One-anastomosis gastric bypass (OAGB) is a bypass bariatric procedure that combines restrictive and malabsorptive components and is associated with anatomical changes in the upper gastrointestinal tract. After this operation, the food stream bypasses the duodenum and the proximal jejunum, which may affect the absorption of oral medications, including semisynthetic penicillins. Objective . To assess the potential effect of OAGB on the bioavailability of oral semisynthetic penicillins and to define clinical pharmacology approaches to their use in patients after this type of bypass bariatric procedure. Materials and methods . A review and clinical pharmacology analysis of published data were performed. The search included studies on anatomical and physiological changes after bariatric surgery, mechanisms of intestinal absorption of amoxicillin, ampicillin, amoxicillin with clavulanic acid, and penicillinase-resistant isoxazolyl penicillins, primarily oxacillin, as well as studies on the pharmacokinetics of oral antibiotics after bypass bariatric procedures. The literature search was conducted in international and Russian scientific databases, including PubMed, Cochrane Library, Google Scholar, Crossref, eLibrary.ru, and CyberLeninka, as well as on the websites of scientific journals and publishers. Publications with verifiable digital object identifiers and Russian sources on bariatric surgery were additionally analyzed. Results and discussion . No direct clinical pharmacokinetic studies of oral semisynthetic penicillins specifically after one-anastomosis gastric bypass were identified in the available literature. Most evidence comes from studies after Roux-en-Y gastric bypass and suggests that systemic exposure to amoxicillin may be unpredictable, especially when solid dosage forms are used. Potentially relevant factors include exclusion of the proximal small intestine, changes in gastric pouch acidity, accelerated intestinal transit, dosage form, hypoalbuminemia, and signs of malabsorption. Conclusion . Oral penicillins after OAGB should not be considered inherently ineffective. However, their use requires assessment of infection severity, dosage form, preserved oral intake, and early clinical response. In severe infection, systemic inflammatory manifestations, or signs of unreliable oral exposure, parenteral administration is preferable.
- 27 July 2026
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 7,p. 26-33
Retraction-associated liver injuries in laparoscopic sleeve gastrectomy: incidence, retraction methods and role of additional assistant
Objective. To assess the incidence and characteristics of retraction-associated liver injuries in laparoscopic sleeve gastrectomy (LSG), different liver retraction techniques and impact of the third assistant on reducing the risk of hepatic injury. Material and methods. We reviewed literature data (2010—2025) and retrospectively analyzed 1089 consecutive LSG procedures. In early phase, rigid retractors, including the Nathanson retractor (n=20), were used. The main cohort consisted of more than 700 procedures performed with a six-port technique and dynamic atraumatic liver retraction by a dedicated third assistant. Additional 150 surgeries were performed by a stable unchanged surgical team. Results. The Nathanson retractor resulted in liver injury in 15% of cases, including capsular tears with bleeding (10%) and segmental ischemia with 8—10-fold elevation of liver enzymes (5%). In six-port technique with the third assistant, the incidence of liver injury was 0.57%. All cases occurred at temporary replacement of experienced assistant. There were no hepatic injuries after 150 consecutive procedures performed by a stable team. Conclusion. Rigid liver retraction—particularly with the Nathanson retractor — is a significant modifiable risk factor for hepatic injury during LSG. The six-port approach, dynamic atraumatic retraction, and inclusion of a dedicated third assistant reduce complication rates. Surgical team stability is a critical determinant of procedural safety.
- 27 July 2026
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 7,p. 26-33
Retraction-associated liver injuries in laparoscopic sleeve gastrectomy: incidence, retraction methods and role of additional assistant
Objective. To assess the incidence and characteristics of retraction-associated liver injuries in laparoscopic sleeve gastrectomy (LSG), different liver retraction techniques and impact of the third assistant on reducing the risk of hepatic injury. Material and methods. We reviewed literature data (2010—2025) and retrospectively analyzed 1089 consecutive LSG procedures. In early phase, rigid retractors, including the Nathanson retractor (n=20), were used. The main cohort consisted of more than 700 procedures performed with a six-port technique and dynamic atraumatic liver retraction by a dedicated third assistant. Additional 150 surgeries were performed by a stable unchanged surgical team. Results. The Nathanson retractor resulted in liver injury in 15% of cases, including capsular tears with bleeding (10%) and segmental ischemia with 8—10-fold elevation of liver enzymes (5%). In six-port technique with the third assistant, the incidence of liver injury was 0.57%. All cases occurred at temporary replacement of experienced assistant. There were no hepatic injuries after 150 consecutive procedures performed by a stable team. Conclusion. Rigid liver retraction—particularly with the Nathanson retractor — is a significant modifiable risk factor for hepatic injury during LSG. The six-port approach, dynamic atraumatic retraction, and inclusion of a dedicated third assistant reduce complication rates. Surgical team stability is a critical determinant of procedural safety.